COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy

PHASE2CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Endometrial Biopsy
Interventions
DRUG

COL-1077

single dose of 150mg lidocaine (10%w/w) administered by intravaginal insertion

DRUG

Placebo

single dose of bioadhesive gel administered by intravaginal insertion

Trial Locations (23)

10038

New York Center for Women's Health Research, New York

12208

Albany Medical College, Albany

27103

Hawthorne Medical Research Inc., Winston-Salem

Lyndhurt Clinical Research (Unified Women's Clinical Research), Winston-Salem

27408

Unified Women's Clinical Research - Greensboro, Greensboro

27612

Wake Research Associates, Raleigh

27713

Carolina Womens Research Wellness Center, Durham

29406

Clinical Trials of South Carolina, Charleston

30328

WR Mount Vernon Clinical Research, LLC, Sandy Springs

33063

South Florida Clinical Research Institute, Margate

33162

Ideal Clinical Research, North Miami Beach

33180

South Florida Medical Research, Aventura

33186

New Age Medical Research Corporation, Miami

33470

Axcess Medical Research, Loxahatchee Groves

68510

Women's Clinic of Lincoln PC, Lincoln

80228

Red Rocks OB/GYN, Lakewood

80923

Bluebird Clinical Trials, Colorado Springs

83404

Rosemark Women Care Specialist, Idaho Falls

84020

Physicians Research Options, Draper

89119

Accent Clinical Trial, Las Vegas

90650

Futura Research, Norwalk

99207

North Spokane Women's Health, Spokane

08648

Lawrence OB-GYN Clinical Research, LLC, Lawrenceville

Sponsors
All Listed Sponsors
lead

Juniper Pharmaceuticals, Inc.

INDUSTRY